Investigation of Differences in P53 Gene Polymorphisms between Schizophrenia and Lung Cancer Patients in the Turkish Population

Table 2

BstUI and MspI polymorphisms of the p53 gene genotype frequencies in Turkish schizophrenia and lung cancer patients and control groups.

	Genotype distribution
	A1-A1		A2-A2		A1-A2
BstUI	𝑛	%	𝑛	%	𝑛	%	𝑋^2	P
Schizophrenia (𝑛=100)	38	38.0	43	43.0	19	19.0	9.620	<.01
Lung cancer (𝑛=100)	5	5.0	87	87.0	8	8.0	129.740	<.001
Controls (𝑛=100)	22	22.0	33	33.0	45	45.0	7.940	<.05
MspI
Schizophrenia (𝑛=100)	0	0.0	46	46.0	54	54.0	.640	.424
Lung cancer (𝑛=100)	13	13.0	43	43.0	44	44.0	18.620	<.001
Controls (𝑛=100)	0	0.0	33	33.0	67	67.0	11.660	<.001

^aDifferences in genotype and allele frequencies; 𝑃<.01 from Fisher’s exact test.